Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The molecular basis of alkaptonuria

J M Fernández-Cañón1, B Granadino, D Beltrán-Valero de Bernabé

  • 1Departmento de Microbiologia Molecular, Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Cientificas, Madrid, Spain.

Nature Genetics
|September 1, 1996
PubMed
Summary

Alkaptonuria (AKU), a rare genetic disorder, is caused by a loss of homogentisate 1,2 dioxygenase (HGO) activity. This study identifies the human HGO gene as the AKU gene, revealing mutations linked to the disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Serum properdin consumption as a biomarker of C5 convertase dysregulation in C3 glomerulopathy.

Clinical and experimental immunology·2015
Same author

Expression of fungal genes involved in penicllin biosynthesis.

World journal of microbiology & biotechnology·2014
Same author

Successful renal transplantation in a patient with atypical hemolytic uremic syndrome carrying mutations in both factor I and MCP.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2009
Same author

Lack of association between polymorphisms in C4b-binding protein and atypical haemolytic uraemic syndrome in the Spanish population.

Clinical and experimental immunology·2008
Same author

[Spanish scientific output on thirty pathologies of genetic origin].

Revista clinica espanola·2008
Same author

Translational mini-review series on complement factor H: genetics and disease associations of human complement factor H.

Clinical and experimental immunology·2007

Area of Science:

  • Human Genetics
  • Metabolic Disorders
  • Molecular Biology

Background:

  • Alkaptonuria (AKU) is historically significant as the first identified Mendelian recessive disease.
  • It's a rare metabolic disorder characterized by the accumulation of homogentisic acid due to deficient homogentisate 1,2 dioxygenase (HGO) activity.
  • Homogentisic acid deposition leads to urine darkening and connective tissue issues, notably debilitating arthritis.

Purpose of the Study:

  • To clone the human HGO gene and confirm its identity as the gene responsible for Alkaptonuria (AKU).
  • To investigate the genetic basis of AKU by analyzing mutations within the HGO gene.

Main Methods:

  • Gene cloning techniques to isolate the human HGO gene.
  • Genetic mapping to determine the chromosomal location of HGO.

Related Experiment Videos

  • Mutation analysis (DNA sequencing) to identify variants in affected individuals.
  • Biochemical assays to assess HGO enzyme function.

    • Main Results:

    • The human HGO gene was successfully cloned and identified as the AKU gene.
    • HGO was mapped to the same chromosomal location previously associated with AKU.
    • Missense mutations within the HGO gene were found to cosegregate with the AKU phenotype.
    • Biochemical evidence confirmed that at least one identified missense mutation results in a loss-of-function of HGO.

    Conclusions:

    • The cloned human HGO gene is definitively the AKU gene.
    • Mutations in the HGO gene are the direct cause of Alkaptonuria.
    • Understanding the genetic basis of AKU provides a foundation for future diagnostic and therapeutic strategies.